Not true. It has conditional marketing authorization. https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#authorisation-details-section https://www.ema

Not true. It has conditional marketing authorization. https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#authorisation-details-section https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty#... Also it is in pharma's interest to have this as long as possible. They like their immunity from prosecution.